THERAPEUTIC EFFECT OF INDUCTION OF POLYGLUTAMYLATION IN HIGH-DOSE METHOTREXATE THERAPY TO PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

被引：0
|
作者：
Fujimoto, Kenji [1 ]
Shinojima, Naoki [1 ]
Makino, Keishi [1 ]
Ichimura, Koichi [2 ]
Mukasa, Akitake [1 ]
机构：
[1] Kumamoto Univ, Dept Neurosurg, Kumamoto, Japan
[2] Natl Canc Ctr, Div Brain Tumor Translat Res, Res Inst, Chuo Ku, Tokyo, Japan
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CBMT-09
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [41] NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma:: Final report
    Herrlinger, U
    Küker, W
    Uhl, M
    Blaicher, HP
    Karnath, HO
    Kanz, L
    Bamberg, M
    Weller, M
    [J]. ANNALS OF NEUROLOGY, 2005, 57 (06) : 843 - 847
  • [42] High-dose methotrexate combined with rituximab improves the survival rate of patients with primary central nervous system lymphoma
    Ma, Jing
    Ma, Xianjun
    [J]. JOURNAL OF BUON, 2021, 26 (02): : 366 - 372
  • [43] Pharmacokinetic monitoring of high-dose methotrexate in primary central nervous system lymphoma: a descriptive case series study
    Garcia-Fumero, R.
    Cano-Dominguez, S.
    Guijarro-Herrera, S.
    Gutierrez-Zuniga, L.
    Alarcon-Payer, C.
    Jimenez-Morales, A.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 364 - 364
  • [44] Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: A single-institution experience
    Ly, K. Ina
    Crew, Laura L.
    Graham, Carrie A.
    Mrugala, Maciej M.
    [J]. ONCOLOGY LETTERS, 2016, 11 (05) : 3471 - 3476
  • [45] HIGH-DOSE METHOTREXATE, HIGH-DOSE CYTARABINE AND TEMOZOLOMIDE FOR THE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL), SIX YEARS SURVIVAL IS REACHED
    Salamoon, M.
    Kenj, M.
    [J]. HAEMATOLOGICA, 2014, 99 : 699 - 699
  • [46] Treatment of Primary Central Nervous System Lymphoma with High-dose Methotrexate and Radiotherapy in HIV-negative Patients
    Jalaeikhoo, Hasan
    Yekaninejad, Mir Saeed
    Hajizamani, Saeideh
    Rahim, Fakher
    Ahmedzadesh, Ahmed
    Keyhani, Manoutchehr
    Hariri, Behrooz Sadeghi
    Saki, Najmaldin
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2015, 18 (09) : 577 - 581
  • [47] High-dose methotrexate in patients with primary central nervous system lymphoma: does drug exposure really matter?
    Joerger, Markus
    Huitema, A. D. R.
    Illerhaus, G.
    Ferreri, A. J. M.
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1825 - 1827
  • [48] Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy
    Luo, Qian
    Yang, Chunli
    Fu, Chunxi
    Wu, Wanchun
    Wei, Yi
    Zou, Liqun
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Clinical significance of polyglutamylation in primary central nervous system lymphoma
    Shinojima, Naoki
    Fujimoto, Kenji
    Makino, Keishi
    Todaka, Kohei
    Yamada, Kazumichi
    Mikami, Yoshiki
    Oda, Kazutaka
    Nakamura, Kazumi
    Jono, Hirofumi
    Kuratsu, Jun-ichi
    Nakamura, Hideo
    Yano, Shigetoshi
    Mukasa, Akitake
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6 : 15
  • [50] Clinical significance of polyglutamylation in primary central nervous system lymphoma
    Naoki Shinojima
    Kenji Fujimoto
    Keishi Makino
    Kohei Todaka
    Kazumichi Yamada
    Yoshiki Mikami
    Kazutaka Oda
    Kazumi Nakamura
    Hirofumi Jono
    Jun-ichi Kuratsu
    Hideo Nakamura
    Shigetoshi Yano
    Akitake Mukasa
    [J]. Acta Neuropathologica Communications, 6
12345